Rogers Earnings 2020-09-30

Balance Sheet	Income Statement	Cash Flow
Assets, Equity	Rev, G Profit, Net Income	Ops, Inv, Fin

rog-20200930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________

FORM 10-Q

_______________________________


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number 1-4347

_______________________________

ROGERS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

_______________________________


Massachusetts			06-0513860
(State or Other Jurisdiction of			(I. R. S. Employer Identification No.)
Incorporation or Organization)

2225 W. Chandler Blvd., Chandler, Arizona 85224-6155

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (480) 917-6000

Securities registered pursuant to Section 12(b) of the Act:


Title of each class		Trading Symbol(s)	Name of each exchange on which registered
Common Stock,	par value $1.00 per share	ROG	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The number of shares outstanding of the registrant’s capital stock as of October 26, 2020 was 18,675,798.

ROGERS CORPORATION

FORM 10-Q

September 30, 2020

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Refer to “Forward-Looking Statements” in Item 2, Management’s Discussion and Analysis of Results of Operations and Financial Position for additional information.

Part I – Financial Information

Item 1. Financial Statements

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollars and shares in thousands, except per share amounts)


	Three Months Ended				Nine Months Ended
	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
Net sales	$	201,944	$	221,842	$	591,911	$	704,492
Cost of sales	126,426		142,975		380,794		454,403
Gross margin	75,518		78,867		211,117		250,089

Selling, general and administrative expenses	50,230		40,448		132,254		127,349
Research and development expenses	7,085		7,830		22,185		23,282
Restructuring and impairment charges	9,413		580		9,413		2,485
Other operating (income) expense, net	(4)		124		(96)		1,075
Operating income	8,794		29,885		47,361		95,898

Equity income in unconsolidated joint ventures	937		1,498		3,177		4,077
Pension settlement charges	—		—		(55)		—
Other income (expense), net	1,446		(918)		1,294		(915)
Interest expense, net	(3,553)		(1,747)		(6,539)		(5,723)
Income before income tax expense	7,624		28,718		45,238		93,337
Income tax expense	618		5,331		10,453		17,258
Net income	$	7,006	$	23,387	$	34,785	$	76,079

Basic earnings per share	$	0.37	$	1.26	$	1.86	$	4.10
Diluted earnings per share	$	0.37	$	1.25	$	1.86	$	4.07

Shares used in computing:
Basic earnings per share	18,688		18,581		18,678		18,569
Diluted earnings per share	18,713		18,724		18,695		18,715

The accompanying notes are an integral part of the condensed consolidated financial statements.

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(Dollars in thousands)


	Three Months Ended				Nine Months Ended
	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
Net income	$	7,006	$	23,387	$	34,785	$	76,079

Foreign currency translation adjustment	11,269		(10,187)		10,004		(12,262)
Pension and other postretirement benefits:
Pension settlement benefits, net of tax (Note 4)	—		—		(48)		—
Actuarial net gain incurred, net of tax (Note 4)	3		—		629		—
Amortization of loss, net of tax (Note 4)	66		172		199		485
Derivative instrument designated as cash flow hedge:
Change in unrealized loss before reclassifications, net of tax (Note 4)	(638)		(158)		(1,504)		(1,362)
Unrealized loss (gain) reclassified into earnings, net of tax (Note 4)	2,810		(32)		2,476		(188)
Other comprehensive income (loss)	13,510		(10,205)		11,756		(13,327)
Comprehensive income	$	20,516	$	13,182	$	46,541	$	62,752

The accompanying notes are an integral part of the condensed consolidated financial statements.

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Unaudited)

(Dollars and shares in thousands, except par value)


	September 30, 2020		December 31, 2019
Assets
Current assets
Cash and cash equivalents	$	186,123	$	166,849
Accounts receivable, less allowance for doubtful accounts of $1,366 and $1,691	138,611		122,285
Contract assets	22,061		22,455
Inventories	109,733		132,859
Prepaid income taxes	3,406		4,524
Asbestos-related insurance receivables, current portion	4,292		4,292
Other current assets	10,217		10,838
Total current assets	474,443		464,102
Property, plant and equipment, net of accumulated depreciation of $370,164 and $341,119	266,104		260,246
Investments in unconsolidated joint ventures	12,755		16,461
Deferred income taxes	26,907		17,117
Goodwill	265,781		262,930
Other intangible assets, net of amortization	132,818		158,947
Pension assets	4,337		12,790
Asbestos-related insurance receivables, non-current portion	74,024		74,024
Other long-term assets	14,871		6,564
Total assets	$	1,272,040	$	1,273,181
Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable	$	35,886	$	33,019
Accrued employee benefits and compensation	35,991		29,678
Accrued income taxes payable	6,235		10,649
Asbestos-related liabilities, current portion	5,007		5,007
Other accrued liabilities	23,237		21,872
Total current liabilities	106,356		100,225
Borrowings under revolving credit facility	60,000		123,000
Pension and other postretirement benefits liabilities	1,654		1,567
Asbestos-related liabilities, non-current portion	80,540		80,873
Non-current income tax	15,509		10,423
Deferred income taxes	9,497		9,220
Other long-term liabilities	11,460		13,973
Commitments and contingencies (Note 10 and Note 12)
Shareholders’ equity
Capital stock - $1 par value; 50,000 authorized shares; 18,676 and 18,577 shares issued and outstanding	18,676		18,577
Additional paid-in capital	145,010		138,526
Retained earnings	858,487		823,702
Accumulated other comprehensive loss	(35,149)		(46,905)
Total shareholders' equity	987,024		933,900
Total liabilities and shareholders' equity	$	1,272,040	$	1,273,181

The accompanying notes are an integral part of the condensed consolidated financial statements.

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Dollars in thousands)


	Nine Months Ended
	September 30, 2020		September 30, 2019
Operating Activities:
Net income	$	34,785	$	76,079
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	48,562		37,176
Equity compensation expense	10,317		9,294
Deferred income taxes	(9,987)		(5,565)
Equity in undistributed income of unconsolidated joint ventures	(3,177)		(4,077)
Dividends received from unconsolidated joint ventures	7,075		5,375
Pension settlement benefits	(63)		—
Pension and other postretirement benefits	(149)		(503)
Asbestos-related charges	—		67
Loss on sale or disposal of property, plant and equipment	49		278
Impairment charges	386		1,537
Provision (benefit) for doubtful accounts	(63)		16
Changes in assets and liabilities:
Accounts receivable	(14,702)		3,668
Contract assets	394		(1,342)
Inventories	25,008		(7,788)
Pension and postretirement benefit contributions	(248)		(16)
Other current assets	1,876		641
Accounts payable and other accrued expenses	5,236		(2,552)
Other, net	8,374		3,384
Net cash provided by operating activities	113,673		115,672

Investing Activities:

Capital expenditures	(28,944)		(38,827)
Proceeds from the sale of property, plant and equipment, net	—		9
Return of capital from unconsolidated joint ventures	—		2,625
Net cash used in investing activities	(28,944)		(36,193)

Financing Activities:
Proceeds from borrowings under revolving credit facility	150,000		—
Repayment of debt principal and finance lease obligations	(213,299)		(98,294)
Payments of taxes related to net share settlement of equity awards	(5,107)		(7,309)
Proceeds from the exercise of stock options, net	—		344
Proceeds from issuance of shares to employee stock purchase plan	1,373		1,249

Net cash provided by (used in) financing activities	(67,033)		(104,010)

Effect of exchange rate fluctuations on cash	1,578		(2,460)

Net increase (decrease) in cash and cash equivalents	19,274		(26,991)
Cash and cash equivalents at beginning of period	166,849		167,738
Cash and cash equivalents at end of period	$	186,123	$	140,747

Supplemental Disclosures:
Accrued capital additions	$	1,493	$	1,999
Cash paid during the year for:
Interest, net of amounts capitalized	$	4,301	$	6,449
Income taxes	$	21,645	$	16,018

The accompanying notes are an integral part of the condensed consolidated financial statements.

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(Unaudited)

(Dollars and shares in thousands)


	Three Months Ended				Nine Months Ended
	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
Capital Stock
Balance, beginning of period	$	18,668	$	18,559	$	18,577	$	18,395
Shares issued for vested restricted stock units, net of shares withheld for taxes	1		2		86		139
Stock options exercised	—		1		—		11
Shares issued for employee stock purchase plan	7		8		13		15
Shares issued to directors	—		2		—		12

Balance, end of period	18,676		18,572		18,676		18,572
Additional Paid-In Capital
Balance, beginning of period	141,092		131,836		138,526		132,360
Shares issued for vested restricted stock units, net of shares withheld for taxes	(79)		113		(5,193)		(7,448)
Stock options exercised	—		16		—		333
Shares issued for employee stock purchase plan	702		647		1,360		1,234
Shares issued to directors	—		(2)		—		(12)
Equity compensation expense	3,295		3,151		10,317		9,294

Balance, end of period	145,010		135,761		145,010		135,761
Retained Earnings
Balance, beginning of period	851,481		829,075		823,702		776,403
Net income	7,006		23,387		34,785		76,079
Cumulative-effect adjustment for lease accounting	—		—		—		(20)
Balance, end of period	858,487		852,462		858,487		852,462
Accumulated Other Comprehensive Loss
Balance, beginning of period	(48,659)		(81,956)		(46,905)		(78,834)
Other comprehensive income (loss)	13,510		(10,205)		11,756		(13,327)
Balance, end of period	(35,149)		(92,161)		(35,149)		(92,161)
Total Shareholders’ Equity	$	987,024	$	914,634	$	987,024	$	914,634

The accompanying notes are an integral part of the condensed consolidated financial statements.

ROGERS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Basis of Presentation

As used herein, the terms “Company,” “Rogers,” “we,” “us,” “our” and similar terms mean Rogers Corporation and its consolidated subsidiaries, unless the context indicates otherwise.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP) for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for their fair presentation in accordance with GAAP. All significant intercompany balances and transactions have been eliminated.

Interim results are not necessarily indicative of results for a full year. For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019. Refer to the discussion below for our restructuring activities significant accounting policy.

We assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to us and the unknown future impacts of COVID-19 as of September 30, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, our allowance for doubtful accounts, equity compensation, the carrying value of our goodwill, other intangible assets as well as other long-lived assets, financial assets, valuation allowances for tax assets and revenue recognition.

Restructuring Activities

We record charges associated with restructuring activities, such as employee termination benefits, which represent a one-time benefit, when management approves and commits to a plan of termination, or over the future service period, if any. Other costs associated with restructuring activities may include contract termination costs, including costs related to leased facilities to be abandoned or subleased, and facility and employee relocation costs.

Note 2 – Fair Value Measurements

The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:

•Level 1 – Quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

As a result of our pension termination and settlement efforts in late 2019 and the first half of 2020, we have a pension surplus investment balance, which is now accounted for as an available-for-sale investment as of June 2020. For additional information regarding this balance, refer to “Note 11 – Pension Benefits and Other Postretirement Benefits.” Available-for-sale investments measured at fair value on a recurring basis, categorized by the level of inputs used in the valuation, were as follows:


	Available-for-Sale Investment at Fair Value as of September 30, 2020
(Dollars in thousands)	Level 1		Level 2		Level 3		Total
Pension surplus investment(1)	$	6,911	$	2,416	$	—	$	9,327

(1) This balance was invested in funds comprised of short-term cash and fixed income securities, and was recorded in the “Other long-term assets” line item in the condensed consolidated statements of financial position. As of September 30, 2020, the fair value of this investment approximated its carrying value.

From time to time we enter into various instruments that require fair value measurement, including foreign currency contracts, copper derivative contracts and interest rate swaps. Derivative instruments measured at fair value on a recurring basis, categorized by the level of inputs used in the valuation, were as follows:


	Derivative Instruments at Fair Value as of September 30, 2020
(Dollars in thousands)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(106)	$	—	$	(106)
Copper derivative contracts	$	—	$	2,640	$	—	$	2,640
Interest rate swap contract	$	—	$	—	$	—	$	—


	Derivative Instruments at Fair Value as of December 31, 2019
(Dollars in thousands)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(6)	$	—	$	(6)
Copper derivative contracts	$	—	$	1,147	$	—	$	1,147
Interest rate swap contract	$	—	$	(1,254)	$	—	$	(1,254)

(1) All balances were recorded in the “Other current assets” or “Other accrued liabilities” line items in the condensed consolidated statements of financial position, except the 2019 interest rate swap balance, which was recorded in the “Other long-term liabilities” line item.

For additional information on derivative contracts, refer to “Note 3 – Hedging Transactions and Derivative Financial Instruments.”

Note 3 – Hedging Transactions and Derivative Financial Instruments

We are exposed to certain risks related to our ongoing business operations. The primary risks being managed through our use of derivative instruments are foreign currency exchange rate risk, commodity pricing risk (primarily related to copper) and interest rate risk. We do not use derivative instruments for trading or speculative purposes. The valuation of derivative contracts used to manage each of these risks is described below:

•Foreign Currency – The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.

•Commodity – The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models, which are collectively a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate and volatility. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date.

•Interest Rates – The fair value of interest rate swap instruments is derived by comparing the present value of the interest rate forward curve against the present value of the swap rate, relative to the notional amount of the swap. The net value represents the estimated amount we would receive or pay to terminate the agreements. Settlement amounts for an “in the money” swap would be adjusted down to compensate the counterparties for cost of funds, and the adjustment is directly related to the counterparties’ credit ratings.

The guidance for the accounting and disclosure of derivatives and hedging transactions requires companies to recognize all of their derivative instruments as either assets or liabilities at fair value in the condensed consolidated statements of financial position. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies for hedge accounting treatment as defined under the applicable accounting guidance. For derivative instruments that are designated and qualify for hedge accounting treatment as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) in the condensed consolidated statements of comprehensive income (loss). This gain or loss is reclassified into earnings in the same line item of the condensed consolidated statements of operations associated with the forecasted transaction and in the same period or

periods during which the hedged transaction affects earnings. As of September 30, 2019, only our interest rate swap qualified for hedge accounting treatment as a cash flow hedge, and the hedge was highly effective.

Foreign Currency

During the three months ended September 30, 2020, we entered into U.S. dollar, euro, and Korean won forward contracts. We entered into these foreign currency forward contracts to mitigate certain global transactional exposures. These contracts do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other (expense) income, net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.

As of September 30, 2020, the notional values of the remaining foreign currency forward contracts were as follows:


Notional Values of Foreign Currency Derivatives
USD/CNH	$	30,138,505
EUR/USD	€	9,430,781
KRW/USD	₩	11,684,000,000

Commodity

As of September 30, 2020, we had 21 outstanding contracts to hedge exposure related to the purchase of copper in our Power Electronics Solutions (PES) and Advanced Connectivity Solutions (ACS) operating segments. These contracts are held with financial institutions and are intended to offset rising copper prices and do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other (expense) income, net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.

As of September 30, 2020, the volume of our copper contracts outstanding was as follows:


Volume of Copper Derivatives
October 2020 - December 2020			201 metric tons per month
January 2021 - March 2021			256 metric tons per month
April 2021 - June 2021			256 metric tons per month
July 2021 - September 2021			222 metric tons per month

Interest Rates

In March 2017, we entered into an interest rate swap to hedge the variable interest rate on $75.0 million of our $450.0 million revolving credit facility. This transaction was designated as a cash flow hedge and qualified for hedge accounting treatment. We terminated the interest rate swap on September 30, 2020. As a result, we settled the interest rate swap for $2.4 million on October 2, 2020, representing the fair value of the interest rate swap on the date of termination. Both Rogers and the counterparties released each other from all obligation under the interest rate swap agreement, including the obligation to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to the agreed upon notional principal amount of $75.0 million. As a result of the termination of the interest rate swap, there is an offsetting decrease in the forecasted interest expense, net over the remaining term of the now-terminated interest rate swap, which was set to expire in February 2022. For additional information regarding our revolving credit facility, refer to “Note 9 – Debt.”

Effects on Financial Statements

The impacts from our derivative instruments on the statement of operations and statements of comprehensive income (loss) were as follows:


		Three Months Ended				Nine Months Ended
(Dollars in thousands)	Financial Statement Line Item	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
Foreign Currency Contracts
Contracts not designated as hedging instruments	Other (expense) income, net	$	(823)	$	181	$	(1,378)	$	(406)
Copper Derivative Contracts
Contracts not designated as hedging instruments	Other (expense) income, net	$	1,238	$	(543)	$	1,067	$	(1,008)
Interest Rate Swap
Contract designated as hedging instrument	Other comprehensive income (loss)	$	2,771	$	(240)	$	1,254	$	(1,985)

Note 4 – Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss by component were as follows:


(Dollars and accompanying footnotes in thousands)	Foreign Currency Translation Adjustments		Pension and Other Postretirement Benefits(1)		Derivative Instrument Designated as Cash Flow Hedge(2)		Total
Balance as of December 31, 2019	$	(35,478)	$	(10,455)	$	(972)	$	(46,905)
Other comprehensive income (loss) before reclassifications	10,004		629		(1,504)		9,129
Amounts reclassified from accumulated other comprehensive loss	—		151		2,476		2,627
Net current-period other comprehensive income (loss)	10,004		780		972		11,756
Balance as of September 30, 2020	$	(25,474)	$	(9,675)	$	—	$	(35,149)

Balance as of December 31, 2018	$	(30,488)	$	(48,700)	$	354	$	(78,834)
Other comprehensive loss before reclassifications	(12,262)		—		(1,362)		(

Price	140.01	EPS	4
Shares	19	P/E	34
MCap	2,622	P/FCF	23
Net Debt	-10	EBIT	93
TEV	2,611	TEV/EBIT	28
TTM 2019-09-30, in MM, except price, ratios

10-Q	2020-09-30	Filed 2020-10-30
10-Q	2020-06-30	Filed 2020-07-31
10-Q	2020-03-31	Filed 2020-05-01
10-K	2019-12-31	Filed 2020-02-21
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-08-01
10-Q	2019-03-31	Filed 2019-05-01
10-K	2018-12-31	Filed 2019-02-21
10-Q	2018-09-30	Filed 2018-11-02
10-Q	2018-06-30	Filed 2018-08-01
10-Q	2018-03-31	Filed 2018-04-27
10-K	2017-12-31	Filed 2018-02-28
10-Q	2017-09-30	Filed 2017-11-03
10-Q	2017-06-30	Filed 2017-08-01
10-Q	2017-03-31	Filed 2017-05-01
10-K	2016-12-31	Filed 2017-02-21
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-09
10-Q	2016-03-31	Filed 2016-05-03
10-K	2015-12-31	Filed 2016-02-23
10-Q	2015-09-30	Filed 2015-10-30
10-Q	2015-06-30	Filed 2015-07-30
10-Q	2015-03-31	Filed 2015-04-30
10-K	2014-12-31	Filed 2015-02-18
10-Q	2014-09-30	Filed 2014-10-29
10-Q	2014-06-30	Filed 2014-07-30
10-Q	2014-03-31	Filed 2014-04-30
10-K	2013-12-31	Filed 2014-02-24
10-Q	2013-09-30	Filed 2013-10-30
10-Q	2013-06-30	Filed 2013-07-31
10-Q	2013-03-31	Filed 2013-05-01
10-Q	2012-09-30	Filed 2012-11-05
10-Q	2012-06-30	Filed 2012-08-01
10-Q	2012-03-31	Filed 2012-05-02
10-Q	2011-09-30	Filed 2011-11-01
10-Q	2011-06-30	Filed 2011-08-02
10-Q	2011-03-31	Filed 2011-05-03
10-K	2010-12-31	Filed 2011-02-18
10-Q	2010-09-30	Filed 2010-11-02
10-Q	2010-06-30	Filed 2010-08-03
10-Q	2010-03-31	Filed 2010-05-04
10-K	2009-12-31	Filed 2010-02-19

8-K	2020-10-29
8-K	2020-10-16
8-K	2020-07-30
8-K	2020-07-30
8-K	2020-05-12
8-K	2020-04-30
8-K	2020-02-20
8-K	2020-02-12
8-K	2019-10-30
8-K	2019-09-03
8-K	2019-07-31
8-K	2019-06-10
8-K	2019-05-21
8-K	2019-05-15
8-K	2019-04-30
8-K	2019-02-20
8-K	2019-02-07
8-K	2018-11-01
8-K	2018-09-17
8-K	2018-08-29
8-K	2018-07-31
8-K	2018-07-09
8-K	2018-05-18
8-K	2018-05-03
8-K	2018-04-26
8-K	2018-03-16
8-K	2018-02-27

EX-31.1	rog-20200930x10ex311.htm
EX-31.2	rog-20200930x10ex312.htm
EX-32	rog-20200930x10ex32.htm
EX-99.1	rogerscorporationemplo.htm


TABLE OF CONTENTS
Part I – Financial Information
	Item 1.	Condensed Consolidated Financial Statements (Unaudited):
		Condensed Consolidated Statements of Operations	3
		Condensed Consolidated Statements of Comprehensive Income (Loss)	4
		Condensed Consolidated Statements of Financial Position	5
		Condensed Consolidated Statements of Cash Flows	6
		Condensed Consolidated Statements of Shareholders’ Equity	7
		Notes to Condensed Consolidated Financial Statements	8
	Item 2.	Management’s Discussion and Analysis of Results of Operations and Financial Position	25
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	39
	Item 4.	Controls and Procedures	39

Part II – Other Information
	Item 1.	Legal Proceedings	40
	Item 1A.	Risk Factors	40
	Item 6.	Exhibits	40
		Signatures	41

ROG 10Q Quarterly Report

Rogers Earnings 2020-09-30